Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 17.33% is 25% above its 5-year average of 13.85%, near the high end of its 5-year range (0.65%–20.76%).
23.79% above its 12-month average of 14.00%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 15.89%.
GROSS MARGIN
17.33%
GROSS MARGIN AVG TTM
14.00%
GROSS MARGIN AVG 3Y
14.92%
GROSS MARGIN AVG 5Y
13.85%
GROSS MARGIN AVG 10Y
13.90%
GROSS MARGIN AVG 15Y
14.04%
GROSS MARGIN AVG 20Y
13.99%
CURRENT VS TTM AVG
+23.79%
CURRENT VS 3Y AVG
+16.13%
CURRENT VS 5Y AVG
+25.17%
CURRENT VS 10Y AVG
+24.69%
CURRENT VS 15Y AVG
+23.46%
CURRENT VS 20Y AVG
+23.84%
SECTOR MEDIAN · HEALTHCARE
39.82%
median of 678 covered companies
CURRENT VS SECTOR MEDIAN
-56.48%
vs the sector median at left
Healthcare Services Group, Inc.
Market Cap
$1.46B
Gross Margin
17.33%
TTM Avg
14.00%
3Y Avg
14.92%
5Y Avg
13.85%
Market Cap
$1.47B
Gross Margin
0.00%
TTM Avg
50.00%
3Y Avg
25.00%
5Y Avg
25.00%
Market Cap
$1.44B
Gross Margin
98.97%
TTM Avg
9.74%
3Y Avg
-353.69%
5Y Avg
-246.22%
Market Cap
$1.50B
Gross Margin
33.71%
TTM Avg
32.28%
3Y Avg
31.46%
5Y Avg
31.45%
Market Cap
$1.43B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.42B
Gross Margin
-91.00%
TTM Avg
-566.75%
3Y Avg
-1506.60%
5Y Avg
-994.02%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Healthcare Services Group, Inc. (HCSG) | $1.46B | 17.33% | 14.00% | 14.92% | 13.85% |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.47B | 0.00% | 50.00% | 25.00% | 25.00% |
| Certara, Inc. (CERT)vs › | $1.48B | 58.33% | 60.70% | 60.53% | 60.29% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.49B | N/A | N/A | N/A | N/A |
| AnaptysBio, Inc. (ANAB)vs › | $1.44B | 98.97% | 9.74% | -353.69% | -246.22% |
| GH Research PLC (GHRS)vs › | $1.50B | 0.00% | 0.00% | 0.00% | 0.00% |
| Phibro Animal Health Corporation (PAHC)vs › | $1.50B | 33.71% | 32.28% | 31.46% | 31.45% |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.43B | 0.00% | 0.00% | 0.00% | 0.00% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.42B | -91.00% | -566.75% | -1506.60% | -994.02% |
| The Pennant Group, Inc. (PNTG)vs › | $1.41B | 14.79% | 13.21% | 12.77% | 12.70% |
Gross Margin
17.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 15.89% |
| 2026-03-31 | 16.39% |
| 2025-12-31 | 16.31% |
| 2025-09-30 | 20.76% |
| 2025-06-30 | 0.65% |
| 2025-03-31 | 15.18% |
| 2024-12-31 | 13.39% |
| 2024-09-30 | 14.81% |
| 2024-06-30 | 9.75% |
| 2024-03-31 | 15.24% |
| 2023-12-31 | 17.33% |
| 2023-09-30 | 8.22% |
| 2023-06-30 | 14.94% |
| 2023-03-31 | 14.87% |
| 2022-12-31 | 13.49% |
| 2022-09-30 | 9.07% |
| 2022-06-30 | 10.71% |
| 2022-03-31 | 12.55% |
| 2021-12-31 | 10.28% |
| 2021-09-30 | 12.22% |
| 2021-06-30 | 15.51% |
| 2021-03-31 | 17.44% |
| 2020-12-31 | 16.77% |
| 2020-09-30 | 16.17% |
| 2020-06-30 | 14.27% |
| 2020-03-31 | 13.80% |
| 2019-12-31 | 13.48% |
| 2019-09-30 | 12.56% |
| 2019-06-30 | 13.33% |
| 2019-03-31 | 10.26% |
| 2018-12-31 | 14.33% |
| 2018-09-30 | 13.35% |
| 2018-06-30 | 13.12% |
| 2018-03-31 | 6.36% |
| 2017-12-31 | 13.36% |
| 2017-09-30 | 13.11% |
| 2017-06-30 | 13.50% |
| 2017-03-31 | 14.57% |
| 2016-12-31 | 14.47% |
| 2016-09-30 | 14.36% |
| 2016-06-30 | 14.06% |
| 2016-03-31 | 14.23% |
| 2015-12-31 | 12.78% |
| 2015-09-30 | 14.30% |
| 2015-06-30 | 14.39% |
| 2015-03-31 | 14.44% |
| 2014-12-31 | 13.25% |
| 2014-09-30 | 1.36% |
| 2014-06-30 | 13.62% |
| 2014-03-31 | 14.35% |
| 2013-12-31 | 11.35% |
| 2013-09-30 | 14.26% |
| 2013-06-30 | 14.25% |
| 2013-03-31 | 14.13% |
| 2012-12-31 | 13.79% |
| 2012-09-30 | 14.08% |
| 2012-06-30 | 13.82% |
| 2012-03-31 | 12.71% |
| 2011-12-31 | 13.21% |
| 2011-09-30 | 14.11% |
| 2011-06-30 | 14.07% |
| 2011-03-31 | 13.63% |
| 2010-12-31 | 14.42% |
| 2010-09-30 | 13.70% |
| 2010-06-30 | 14.36% |
| 2010-03-31 | 13.73% |
| 2009-12-31 | 13.03% |
| 2009-09-30 | 13.20% |
| 2009-06-30 | 14.67% |
| 2009-03-31 | 14.04% |
| 2008-12-31 | 13.23% |
| 2008-09-30 | 12.26% |
| 2008-06-30 | 14.09% |
| 2008-03-31 | 14.54% |
| 2007-12-31 | 14.20% |
| 2007-09-30 | 14.11% |
| 2007-06-30 | 14.95% |
| 2007-03-31 | 15.19% |
| 2006-12-31 | 15.30% |
| 2006-09-30 | 13.75% |
| 2006-06-30 | 13.84% |
| 2006-03-31 | 14.07% |
| 2005-12-31 | 13.40% |
| 2005-09-30 | 12.58% |
| 2005-06-30 | 12.64% |
| 2005-03-31 | 31.05% |
| 2004-12-31 | 12.24% |
| 2004-09-30 | 12.18% |
| 2004-06-30 | 11.90% |
| 2004-03-31 | 12.40% |
| 2003-12-31 | 11.40% |
| 2003-09-30 | 12.03% |
| 2003-06-30 | 12.04% |
| 2003-03-31 | 12.11% |
| 2002-12-31 | 11.73% |
| 2002-09-30 | 12.08% |
